May 8-9, Modern Radiation For Lymphoma. NEW YORK CITY UPDATED ROLE AND NEW RULES

Transcription

1 Modern Radiation For Lymphoma May 8-9, 2015 COURSE DIRECTOR Joachim Yahalom MD CHAIRMAN International Lymphoma Radiation Oncology Group MEMBER AND PROFESSOR Memorial Sloan Kettering Cancer Center CONFERENCE LOCATION Memorial Sloan Kettering Cancer Center ZUCKERMAN RESEARCH CENTER 417 East 68th Street, New York (Between First and York Avenues) NEW YORK CITY

2 COURSE OVERVIEW Presentations of advances in clinical options and translational research for various lymphomas and clinical scenarios with a focus on the updated role of radiotherapy, modern RT technologies, and new guidelines for RT dose and fields. Six travel grants will be awarded in the amounts of $500 for participants from North America and $1000 for participants from other continents. COURSE DIRECTOR HONORARY SPEAKERS INVITED SPEAKERS Joachim Yahalom MD Chairman, International Lymphoma Radiation Oncology Group Member and Professor, MSK Saul Rosenberg MD Stanford, CA, USA Riccardo Dalla-Favera MD New York, NY, USA Samuel Hellman MD Chicago, IL, USA Andreas Engert MD Cologne, Germany This program has been organized by The International Lymphoma Radiation Oncology Group and Memorial Sloan Kettering Cancer Center Nancy Lee Harris MD Boston, MA, USA This program is co-sponsored by the American Society For Radiation Oncology This program has been endorsed by the European Society For Radiotherapy & Oncology Gerhard Held MD Saarland, Germany

3 COURSE DIRECTOR Joachim Yahalom MD Chairman, International Lymphoma Radiation Oncology Group Member and Professor, MSK MSK SPEAKERS Lisa DeAngelis, MD Ahmet Dogan, MD, PhD Steve Horwitz, MD Craig Moskowitz, MD Carol Portlock, MD Anas Younes, MD Andrew Zelenetz, MD, PhD ILROG FACULTY SPEAKERS Berthe Aleman, MD, PhD Amsterdam, The Netherlands Louis S. Constine, MD Rochester, NY, USA Bouthaina Dabaja, MD Houston, TX, USA Hans T. Eich, MD, PhD Münster, Germany David Hodgson, MD Toronto, Ontario, Canada Bradford Hoppe, MD Jacksonville, FL, USA Richard Hoppe, MD Stanford, CA, USA Theodore Girinsky, MD Paris, France Tim Illidge, MD, PhD Manchester, England, UK Youlia Kirova, MD Paris, France Yexiong Li, MD Beijing, China Peter Mauch, MD Boston, MA, USA George Mikhaeel, MD London, England, UK Andrea Ng, MD Boston, MA, USA Rahul Parikh, MD New York, NY, USA Umberto Ricardi, MD Torino, Italy Lena Specht, MD, PhD Copenhagen, Denmark Stephanie Terezakis, MD Baltimore, MD, USA Richard Tsang, MD Toronto, Ontario, Canada Andrew Wirth, MD East Melbourne, Victoria, Australia

4 Friday, May 8: Morning 7:00-8:00am 8:00-8:10am 8:10-8:20am 8:20-9:00am 9:00-9:15am 9:15-9:30am 9:30-10:00am REGISTRATION AND BREAKFAST INTRODUCTION SESSIONS INTRODUCTION Joachim Yahalom, MD WELCOME Jose Baselga, MD, Physician in Chief, MSK MEDICINE AND RADIATION ONCOLOGY GRAND ROUNDS ILROG KEYNOTE LECTURE Milestones in the Treatment of Hodgkin Lymphoma: What s Next? Andreas Engert, MD End of Grand Rounds (short break) Introduction of Saul Rosenberg, MD Richard Hoppe, MD Hodgkin s Disease: A 50-Year Perspective Saul Rosenberg, MD 10:00-10:15am 10:15-10:35am 10:35-11:05am 11:05-11:35am COFFEE BREAK PATHOLOGY & IMMUNOLOGY SESSION MODERATOR: Ahmet Dogan, MD, PhD WHO Lymphoma Classification Update Nancy Lee Harris, MD Hot Issues in Lymphoma Pathology: Impact of Genomic Studies on Diagnosis of Lymphoma Ahmet Dogan, MD, PhD Molecular Pathogenesis of B Cell Lymphoma Ricardo Dalla-Favera, MD 11:35am-12:00pm Immunological Modulation in the Treatment of Lymphoma: Present and Future Tim Illidge, MD, PhD

5 Friday, May 8: Afternoon 12:00-1:00pm 1:00-3:00pm 1:00-1:10pm 1:10-1:40pm 1:40-2:00pm 2:00-2:20pm 2:20-2:40pm 2:40-3:00pm 3:00-3:15pm 3:15-4:15pm 3:15-3:40pm 3:40-4:00pm 4:00-4:15pm 4:15-5:15pm 4:15-5:15pm LUNCH AND DIGITAL POSTER PRESENTATION HODGKIN LYMPHOMA: ROLE OF RADIATION MODERATOR: Peter Mauch, MD Introduction of Samuel Hellman, MD Peter Mauch, MD What Thomas Hodgkin Can Teach Us Samuel Hellman, MD Staging and Response Assessment in Lymphoma George Mikhaeel, MD EORTC H10 and Future European Studies Lena Specht, MD, PhD HD6 and RAPID Study: Should It Change Practice? Tim Illidge, MD, PhD Survival Analysis in Hodgkin Lymphoma: Large Data Bases Rahul Parikh, MD COFFEE BREAK LOW RT DOSE STRATEGIES MODERATOR: Richard Tsang, MD Primary CNS Lymphoma Lisa DeAngelis, MD Indolent Lymphomas Andrew Wirth, MD COFFEE BREAK CASE DISCUSSION: HODGKIN LYMPHOMA MODERATOR: David Hodgson, MD CASE DISCUSSION PANELISTS: Stephanie Terezakis, MD; Hans T. Eich, MD, PhD; Carol Portlock, MD; Peter Mauch, MD; Youlia Kirova, MD

6 Saturday, May 9: Morning 7:00-8:00am 8:00-8:20am 8:20-8:40am 8:40-9:00am 9:00-9:20am 9:20-9:45am BREAKFAST AGGRESSIVE LYMPHOMAS MODERATOR: Bouthaina Dabaja, MD Biomarker Driven Treatment Selection in DLBCL Andrew Zelenetz, MD, PhD The Role of Radiotherapy in the Treatment of DLBCL: A Perspective of The German High-Grade Non-Hodgkin Lymphoma Study Group Gerhard Held, MD More Evidence of Benefit (and less toxicity) for Radiation Therapy in Large-Cell Lymphoma Bouthaina Dabaja, MD High Dose Salvage for Non Hodgkin Lymphoma and Hodgkin Lymphoma Craig Moskowitz, MD New Treatment Options in Lymphoma Anas Younes, MD 9:45-10:00am COFFEE BREAK SKIN AND T-CELL LYMPHOMAS MODERATOR: Richard Hoppe, MD 10:00-10:20am Systemic Therapy for T-Cell Lymphoma Steve Horwitz, MD 10:20-10:40am 10:40-11:00am Prognosis and Treatment of Extranodal NK/T-Cell Lymphoma, Nasal-Type Yexiong Li, MD Radiotherapy of Mycosis Fungoides Richard Hoppe, MD 11:00am-12:30pm CASE DISCUSSION: NON-HODGKIN LYMPHOMA MODERATOR: Bouthaina Dabaja, MD 11:00am-12:30pm CASE DISCUSSION PARTICIPANTS: Anas Younes, MD; Gerhard Held, MD; Richard Tsang, MD; Yexiong Li, MD

7 Saturday, May 9: Afternoon 12:30-2:00pm 12:30-2:00pm 2:00-3:00pm 2:00-2:20pm 2:20-2:40pm 2:40-3:00pm LUNCH AND DIGITAL POSTER PRESENTATION LUNCH AND MEETING OF THE STEERING COMMITTEE AND COUNCIL NEW FIELDS CONCEPT AND NEW TECHNOLOGY MODERATOR: Umberto Ricardi, MD Concepts of ISRT and DIBH Theodore Girinsky, MD IMRT / IGRT Techniques: How Do We Decide About It? Umberto Ricardi, MD Proton Therapy for Lymphoma: Pros and Cons Bradford Hoppe, MD 3:00-3:20 pm COFFEE BREAK 3:20-3:40pm 3:40-4:00pm 4:00-4:20pm LONG-TERM COMPLICATIONS MODERATOR: Berthe Aleman, MD, PhD Second Malignancies Berthe Aleman, MD, PhD The Heart after Lymphoma Therapy: The Beat Goes On (usually)! Louis S. Constine, MD Surveillance and Prevention of Long-Term Morbidity Andrea Ng, MD 4:20-4:30pm CONCLUSION Joachim Yahalom, MD

8 On the evening of Friday, May 8, join us to Celebrate New York at the Museum of the City of New York! Included for you and a guest is a cocktail reception, dinner, and private tour of the galleries. RSVP by Thursday, April 30

9 Saturday, May 9, 2015 ILROG LEADERSHIP DINNER Metropolitan Museum of Art th Avenue, New York 6:30pm Cocktail Reception 7:15pm Dinner

10 REGISTRATION EARLY BIRD* GENERAL $250 $350 MDs, PhDs and DOs $50 $50 Fellows, Residents and RNs * Deadline is March 1, Registration fee includes an electronic syllabus and other related hand-out materials, continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with special dietary needs. For more information or to register to attend please go to: Or contact the: OFFICE OF CONTINUING MEDICAL EDUCATION Memorial Sloan Kettering Cancer Center 633 Third Avenue, 12th floor, New York, New York (646) brodheap@mskcc.org TARGET AUDIENCE Radiation oncologists and other health care professionals involved in treating patients with lymphoma. COURSE DESIGN Presentations of advances in clinical options and translational research for various lymphomas and clinical scenarios with a focus on the updated role of radiotherapy, modern RT technologies, and new guidelines for RT dose and fields. EVALUATION A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs. ACCREDITATION STATEMENT MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA CREDIT DESIGNATION STATEMENT MSK designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 13.5 AMA PRA Category 1 Credit(s). FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational. OUTCOMES MEASUREMENT SURVEY Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course. HOTEL RESERVATIONS For hotel availability and special rates close to MSK, go to: Please feel free to contact the CME Office for further assistance as needed at: johnsonf@mskcc.org

11 Please be sure to mark your calendars for upcoming 2015 MSK CME COURSES ACCREDITATION STATEMENT MSK is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. To register or for more information, contact: OFFICE OF CONTINUING MEDICAL EDUCATION Memorial Sloan Kettering Cancer Center 633 Third Avenue, 12th Floor, New York, New York (646) Or register online: For course updates, follow: facebook.com/mskcme or on HPV and The Cancer Connection April 8 Multidisciplinary Spine Apr 17 Oncology Symposium LGBT Allies Training April (TBD) SCLC Conference April Pelvic MRI Course April Overuse: A Quality Problem April 29 In and Out of The Hospital Care of the Older Adult Across May 1 The Cancer Continuum Symposium LGBT Health Workforce May 1-3 Pathology of Neoplastic Disease May 4-8 Modern Radiation for May 8, 9 Lymphoma Radioactive Seed Localization May 11 Oncologic Imaging May Thrombosis and Hemostasis May 17 SPARC May 19 Ovarian Cancer June 5-6 Trudy N. Small Symposium June 19 Thoracic Pathology NYC September Robotics (w/ MDACC) September Endobronchial Ultrasound September Interventional Bronchoscopy Thoracic Surgical Oncology October 2-3 Oncologic FDG PET/CT October 9-10 Genetics and Genomics of October Gynecologic Cancers Defining the Actionable Genome October Spotlight On ALL October 18 Dermatology Through The October 22 Lens of Medical Informatics Dermatologic Care October 23 Dermoscopy Intermediate October Musculoskeletal Tumor Pathology October Urologic Cancers October Complex Skin Cancers November International Ovarian Cancer December 4-5